Breaking News, Collaborations & Alliances

Amarna Therapeutics and NorthX Biologics Partner on Gene Therapy

Will advance the clinical trial manufacturing of Nimvec AM510, Amarna’s gene therapy platform designed to transform the treatment of immune-mediated diseases.

Author Image

By: Charlie Sternberg

Associate Editor

Amarna Therapeutics, a privately held biotechnology company specializing in transformative gene therapies, has entered a strategic collaboration with NorthX Biologics, a biologics manufacturing partner, which aims to advance the clinical trial manufacturing of Nimvec AM510, Amarna’s gene therapy platform designed to transform the treatment of immune-mediated diseases.   The collaboration will begin with the transfer of Amarna’s research-scale production process for Nimvec AM510 to NorthX Biolo...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters